Flow cytometry using annexin V can detect early apoptosis in peripheral blood stem cell harvests from patients with leukaemia and lymphoma

Bone Marrow Transplantation

Volumn 21, Issue 5, 1998, Pages 441-446

  Anthony, R S ^a   McKelvie, N D ^a   Cunningham, A J ^a   Craig, J I O ^a   Rogers, S Y ^b   Parker, A C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Annexin V; Apoptosis; CD34; PBSC

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; BONE MARROW PURGING; CELL SELECTION; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0031885432     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701134     Document Type: Article

References (28)

1. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients - enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
2. Haas R, Hohaus S, Egerer G et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant 1992; 9: 459-465.
3. Siena S, Bregni M, Di Nicola M et al. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 1994; 5: 935-941.
4. Haas R, Witt B, Möhle R et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor support. Blood 1995; 85: 3754-3761.
5. To LB, Haylock DN, Kimber RJ et al. High levels of circulating haematopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 1984; 58: 399-410.
6. Craig JIO, Smith SM, Parker AC et al. The response of peripheral blood stem cells to standard chemotherapy for lymphoma. Leuk Lymphoma 1992; 6: 363-368.
7. Craig JIO, Anthony RS, Stewart A et al. Peripheral blood stem cell mobilisation using high-dose CY and G-CSF in pretreated patients with lymphoma. Br J Haematol 1993; 85: 210-212.
8. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
9. Haas R, Möhle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
10. Iwai K, Miyawaki T, Takizawa T et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils. Blood 1994; 84: 1201-1208.
11. Darzynkiewicz Z, Bruno S, del Bino G et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795-808.
12. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Meth 1994; 172: 1-16.
13. Facchinetti A, Tessarollo L, Mazzocchi M et al. An improved method for the detection of DNA fragmentation. J Immunol Meth 1991; 136: 125-131.
14. Telford WG, King LE, Fraker PJ. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 1992; 13: 137-143.
15. Schmid I, Uittenbogaart C, Keld B et al. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Meth 1994; 170: 145-157.
16. Vermes I, Haanen C, Steffens-Nakken H et al. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Meth 1995; 184: 39-51.
17. Fadok VA, Voelker DR, Campbell PA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
18. Koopman G, Reutelingsperger CPM, Kuijten GAM et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
19. Homberg CHE, de Haas M, von dem Borne AEG et al. Human neutrophils lose their surface Fc gamma RIII and acquire annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532-540.
20. Martin SJ, Reutelingsperger CPM, McGahon AJ et al. Early redistribution of plasma membrane phosphatidyl serine is a general feature of apoptosis regardless of the initiating stimulus; inhibited by overexpression of bcl-2 and abl. J Exp Med 1995; 182: 1545-1556.
21. Cohen GM, Sun XM, Snowden RT et al. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992; 286: 331-334.
22. Haas R, Möhle R, Murea S et al. Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factor. J Hematother 1994; 3: 323-330.
23. + cells in apheresis products from patients mobilized from peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994; 13: 479-485.
24. + cells: role of G-CSF as survival factor. Br J Haematol 1997; 97: 146-152.
25. Verbik DJ, Jackson JD, Pirruccello SJ et al. Functional and phenotypic characterisation of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 1995; 85: 1964-1970.
26. Serke S, Säuberlich S, Huhn D et al. Multiparameter flow cytometric quantitation of circulating CD34-positive cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assay. Br J Haematol 1991; 77: 453-459.
27. + cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1993; 19: 1079-1083.
28. Chabannon C, le Coroller A-G, Faucher C et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 1995; 4: 171-179.